BridgeBio Pharma (BBIO) Stock Forecast for 2023 – 2026. Sell or Buy Prediction

BridgeBio Pharma (BBIO) Stock Forecast for 2023 – 2026. Sell or Buy?

Updated: December 3, 2023 (10:15)

Sector: Healthcare

The share price of BridgeBio Pharma, Inc. (BBIO) now

What analysts predict: $46.18
52-week High/Low: $36.36 / $6.64

50/200 Day Moving Average: $26.86 / $21.26

This figure corresponds to the Average Price over the previous 50/200 days. For BridgeBio Pharma stocks, the 50-day moving average is the support level today.

For BridgeBio Pharma stocks, the 200-day moving average is the support level today.

Are you interested in BridgeBio Pharma, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the BridgeBio Pharma stock price in 2023, 2024, 2025, 2026, 2027. How much will one BridgeBio Pharma share be worth in 2023 - 2027?

When should I take profit in BridgeBio Pharma stock? When should I record a loss on BridgeBio Pharma stock? What are analysts' forecasts for BridgeBio Pharma stock? What is the future of BridgeBio Pharma stock? We forecast BridgeBio Pharma stock performance using neural networks based on historical data on BridgeBio Pharma stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

BridgeBio Pharma stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2023, 2024, 2025, 2026 and 2027) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for BridgeBio Pharma shares. This happens once a day.




Historical and forecast chart of BridgeBio Pharma stock

The chart below shows the historical price of BridgeBio Pharma stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the BridgeBio Pharma stock price can be found in the table below.

Long-term forecasts by years.

BridgeBio Pharma, Inc. is engaged in the discovery, development and supply of various drugs for genetic diseases. The company has a portfolio of 20 development programs that include candidate products from early discovery to late development.

BridgeBio Pharma daily forecast for a month

Date Target Pes. Opt. Vol., %
Dec 05 31.07 30.20 31.55 4.49
Dec 06 31.37 30.47 32.01 5.07
Dec 07 30.74 29.83 31.47 5.49
Dec 08 30.25 29.36 30.97 5.49
Dec 09 30.37 29.98 30.82 2.77
Dec 10 31.46 31.01 32.33 4.24
Dec 11 31.20 30.80 31.85 3.41
Dec 12 31.25 30.75 32.04 4.21
Dec 13 30.63 30.34 30.95 2.02
Dec 14 30.36 29.81 31.15 4.48
Dec 15 29.92 29.31 30.60 4.38
Dec 16 29.59 29.01 29.88 2.98
Dec 17 30.49 29.64 31.10 4.91
Dec 18 31.45 30.82 31.83 3.28
Dec 19 31.39 30.58 31.82 4.06
Dec 20 30.81 30.44 31.55 3.63
Dec 21 31.40 30.82 31.95 3.66
Dec 22 30.91 30.36 31.25 2.90
Dec 23 29.87 29.10 30.45 4.63
Dec 24 29.41 28.81 30.21 4.87
Dec 25 29.47 28.92 30.22 4.49
Dec 26 28.99 28.57 29.42 3.00
Dec 27 29.57 29.04 30.41 4.71
Dec 28 29.45 28.65 29.94 4.53
Dec 29 29.77 29.39 30.42 3.48
Dec 30 30.80 30.22 31.15 3.05
Dec 31 31.35 30.86 32.05 3.83
Jan 01 31.57 30.74 31.89 3.72
Jan 02 30.63 29.93 31.23 4.32
Jan 03 30.26 30.03 30.82 2.65

BridgeBio Pharma Daily Price Targets


BridgeBio Pharma Stock Forecast 12-05-2023.

Forecast target price for 12-05-2023: $31.07.
Positive dynamics for BridgeBio Pharma shares will prevail with possible volatility of 4.299%.
Pessimistic target level: 30.20
Optimistic target level: 31.55

BridgeBio Pharma Stock Forecast 12-06-2023.

Forecast target price for 12-06-2023: $31.37.
Positive dynamics for BridgeBio Pharma shares will prevail with possible volatility of 4.823%.
Pessimistic target level: 30.47
Optimistic target level: 32.01

BridgeBio Pharma Stock Forecast 12-07-2023.

Forecast target price for 12-07-2023: $30.74.
Negative dynamics for BridgeBio Pharma shares will prevail with possible volatility of 5.205%.
Pessimistic target level: 29.83
Optimistic target level: 31.47

BridgeBio Pharma Stock Forecast 12-08-2023.

Forecast target price for 12-08-2023: $30.25.
Negative dynamics for BridgeBio Pharma shares will prevail with possible volatility of 5.205%.
Pessimistic target level: 29.36
Optimistic target level: 30.97

BridgeBio Pharma Stock Forecast 12-09-2023.

Forecast target price for 12-09-2023: $30.37.
Positive dynamics for BridgeBio Pharma shares will prevail with possible volatility of 2.698%.
Pessimistic target level: 29.98
Optimistic target level: 30.82

BridgeBio Pharma Stock Forecast 12-10-2023.

Forecast target price for 12-10-2023: $31.46.
Positive dynamics for BridgeBio Pharma shares will prevail with possible volatility of 4.068%.
Pessimistic target level: 31.01
Optimistic target level: 32.33

BBIO (BBIO) Monthly Stock Prediction for 2023

Month Target Pes. Opt. Vol., %
Dec. 30.72 27.76 33.00 15.86

BridgeBio Pharma forecast for this year


BridgeBio Pharma Stock Prediction for Dec 2023

An downtrend is forecast for this month with an optimal target price of $30.7194. Pessimistic: $27.76. Optimistic: $33.00



BridgeBio Pharma (BBIO) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Jan 31.52 29.47 34.76 15.21
Feb 31.15 28.19 32.89 14.28
Mar 28.76 25.92 30.85 16.00
Apr 28.61 26.49 30.40 12.85
May 29.39 28.59 30.16 5.19
Jun 28.17 26.63 30.55 12.83
Jul 26.92 24.44 28.46 14.14
Aug 27.03 25.06 29.70 15.62
Sep 28.22 25.80 29.91 13.74
Oct 28.08 25.59 30.08 14.92
Nov 26.07 24.82 28.07 11.59
Dec 25.15 22.87 26.20 12.73

BridgeBio Pharma (BBIO) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 24.27 22.32 26.64 16.23
Feb 25.57 23.40 27.83 15.89
Mar 28.89 27.65 30.32 8.80
Apr 30.95 27.78 33.21 16.36
May 34.58 32.60 35.61 8.46
Jun 34.98 32.12 36.71 12.51
Jul 35.71 33.57 38.26 12.25
Aug 36.26 33.95 38.01 10.67
Sep 35.89 34.86 38.31 9.01
Oct 37.75 36.09 39.82 9.37
Nov 39.18 35.56 42.90 17.10
Dec 39.13 36.28 42.69 15.01

BridgeBio Pharma (BBIO) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 38.52 34.61 41.72 17.04
Feb 36.11 34.05 39.16 13.07
Mar 36.54 35.11 40.19 12.64
Apr 32.83 31.68 35.73 11.35
May 31.34 30.20 33.37 9.52
Jun 28.24 26.37 29.93 11.90
Jul 26.81 25.24 27.85 9.38
Aug 28.34 26.06 29.78 12.50
Sep 28.45 26.68 29.71 10.21
Oct 31.86 30.94 34.84 11.17
Nov 29.99 28.90 31.40 7.95
Dec 30.15 28.42 31.28 9.15

BridgeBio Pharma (BBIO) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 31.21 28.16 33.23 15.26
Feb 29.22 26.90 29.98 10.26
Mar 27.62 26.73 29.17 8.37
Apr 26.04 24.66 28.07 12.18
May 27.53 26.42 29.57 10.65
Jun 27.10 24.57 28.94 15.10
Jul 26.75 24.80 29.22 15.11
Aug 29.64 26.63 31.29 14.90
Sep 28.75 26.70 30.21 11.63
Oct 31.26 29.71 33.33 10.85
Nov 30.56 28.70 32.27 11.08
Dec 32.71 31.39 33.65 6.70

BridgeBio Pharma information and performance

BridgeBio Pharma Address

421 KIPLING STREET, PALO ALTO, CA, US

Market Capitalization: 5 144 204 000 $

Market capitalization of the BridgeBio Pharma, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of BBIO shares in the company outstanding by the market price of one share.

EBITDA: -537 753 984 $

EBITDA of BridgeBio Pharma is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: None

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -3.91

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: 11.1
Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 28.78

Enterprise Value (EV) /Revenue

EV To EBITDA: -6.16

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 173967000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A



Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.